About this episode
Today, I'm joined by Geoff Cook, CEO of Noom. Evolved from behavior change app to clinical health platform, Noom combines personalized coaching with medications like GLP-1s to forge better habits and drive long-term health outcomes. In this episode, we discuss using medication as a catalyst for behavior change. We also cover: Shifting revenue driven by medicated plans Microdosing GLP-1s Building the "Duolingo of Health" Subscribe to the podcast ? insider.fitt.co/podcast Subscribe to our newsletter ? insider.fitt.co/subscribe Follow us on LinkedIn ? linkedin.com/company/fittinsider Website: www.noom.com Programs for weight loss and proactive health available - The Fitt Insider Podcast is brought to you by EGYM. Visit EGYM.com to learn more about its smart fitness ecosystem for fitness and health facilities. Fitt Talent: https://talent.fitt.co/ Consulting: https://consulting.fitt.co/ Investments: https://capital.fitt.co/ Chapters: (00:00) Introduction (01:30) What's changed at Noom (02:00) Revenue shift (03:25) GLP-1s as catalyst (04:20) Food noise silence (05:35) Discontinuation rates (06:35) Medication to maintenance (07:00) Microdosing GLP-1s (08:35) Challenges and strategies (09:50) Self-experimentation & preventative health (12:20) Other supplements (14:05) Stacking habits (15:35) What belongs in clinical care? (16:20) Litmus test (17:20) Research investment and peer-reviewed studies (18:25) Largest microdose dataset in the world (19:30) Virtuous loop (20:30) Cue, micro-habit, reward framework (21:25) Gamification (22:32) Behavior change foundation (24:00) Condition advanta
